10
Diagnosis
Figure 2. Detection of White Coat Effect or Masked
Uncontrolled Hypertension in Patients on Drug
Therapy
Colors correspond to Class of Recommendation on page 56–57.
Detection of white coat effect or masked uncontrolled
hypertension in patients on drug therapy
HBPM BP
at goal
Office BP
at goal
Screen for
masked
uncontrolled
hypertension with
HBPM
(Class IIb)
YES NO
Continue current
therapy
YES NO
Increased
CVD risk or
target organ
damage
YES
NO
YES NO
Office BP
≥5–10 mm Hg
above goal on
≥3 agents
Screening
not necessary
(No Benefit)
Screen for white
coat effect with
HBPM
(Class IIb)
YES
NO
Screening
not necessary
(No Benefit)
HBPM BP
above goal
ABPM BP
above goal
Masked uncontrolled
hypertension:
Intensify therapy
(Class IIb)
White coat
effect: Confirm
with ABPM
(Class IIa)
Continue
titrating
therapy
